Skip to content

Study To Access The Efficacy Of Kadalikshar Lepa In The Management of Sidhma Kushta With Special Reference TINEA VERSICOLOR IN CHILDREN.

Single Arm Clinical Study To Access The Efficacy Of Kadalikshar Lepa In The Management Of Sidhma Kushtha With Special Reference To Tinea Versicolor in Children - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072425
Enrollment
40
Registered
2024-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Pramod shelke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children diagnosed with Sidhma kushtha. -Children between 8- 14 years of age group irrespective of sex, caste, religion and socioeconomic status.

Exclusion criteria

Exclusion criteria: Children suffering with known case of any autoimmune disorder. -Children with known case of chronic skin disease other than Sidhma or allergic skin disease. -Children of Sidhma Kushtha with Secondary infections.

Design outcomes

Primary

MeasureTime frame
To study the effect of “kadalikshar Lepa ? in the management of Sidhma Kushtha With special reference to Tinea versicolor in children .Timepoint: 21 days study with follow up on 7th 15th 21st day

Secondary

MeasureTime frame
1)To study the efficacy of “Kadalikshar Lepa ?in children with Ayurvedic perspective in detail. 2) To study the literature related to Sidhma Kushtha. 3) To study the etiopathogenesis of ‘Sidhma kushtha’in children from ayurvedic & contemporary medical literature. 4) To study the concept of Lepa preparation.Timepoint: 21 days study with follow up on 7th 15th 21st day

Countries

India

Contacts

Public ContactDr Masaudaalam Mujawar

LRP Ayurvedic medical college and hospital, PG Institute and Research center

dr.masudaalam10@gmail.com9823645588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026